PharmaBoardroom

Argentina Pharma Industry: Scenario in Early 2020

On October 27th, 2019, presidential candidate Alberto Fernández was elected president of Argentina defeating the Macri Administration with more than…

Opportunities to Fix Medicare Part D

The Association for Accessible Medicines' Chip Davis outlines the ways in which the US Medicare programme needs updating in order to promote generic…

Bernard Bauer – CEO & Board Member, German-Czech…

Bernard Bauer, CEO and board member at the German-Czech Chamber of Industry and Commerce, discusses the factors that make the German-Czech…

Pál Szamosújvári – Founder, Pál Szamosújvári Jr…

MD Pál Szamosújvari, Judit Jávor, Pál Szamosújvari Jr—Founder, R&D Director, and Director of Pharma Patent respectively—share their…

Czech Drug Shortages: Both Local & International Solutions…

Medicine shortages are a European-wide issue. In 2016, the European Medicines Agency (EMA) and the Heads of Medicines Agencies (HMA) formed a task…

Biosimilars and Biologics: Algeria

A brief overview of the situation regarding biosimilars and biologics. Prepared in association with SAARPE Association, a leading law firm in Algeria,…

Localization: Algeria

The ins and outs of localization in Algeria. Prepared in association with SAARPE Association, a leading law firm in Algeria, this is an extract from…

Orphan Drugs and Rare Diseases: Algeria

A brief overview of the situation regarding orphan drugs and rare diseases in Algeria. Prepared in association with SAARPE Association, a leading law…